Immunosuppressive Drugs Are A Double-edged Sword To Type 1 Diabetics
Although insulin injections have changed the life of type I diabetics, they neither cure the disease nor prevent its severe complications. It was hoped that islet transplantation would provide a cure, however, transplant success is short-lived and accompanied by significant side effects.
New data from Yuval Dor and colleagues at the Hebrew University-Hadassah Medical School, Jerusalem, have indicated that the immunosuppressive drugs used to prevent rejection of islet transplants suppress beta-cell regeneration in diabetic mice.
As mentioned by the authors and discussed in the accompanying commentary by Klaus Kaestner from the University of Pennsylvania, Philadelphia, this raises the possibility that if immunosuppressive drugs that do not inhibit beta-cell regeneration can be identified successful regenerative islet transplantation might become a reality.
Article: Recovery from diabetes in mice by beta-cell regeneration
Article based on information provided by: Journal of Clinical Investigation, Ann Arbor, Michigan U.S.A.
Adapted and published by: Mooshee.com
Originally released on: September 10
Next Article: New Viruses Implicated In Respiratory Infections And Asthma Attacks
More Articles On: Diabetes, Lymphoma, Immune System, Pharmacology, Alzheimer's, Hormones,